CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±è¼ºÇý
  • ¼Ò ¼Ó: ºÐ´çÂ÷¿©¼ºº´¿ø
  • Àü¹®ºÐ¾ß : ¼Ò¾Æ½ÉÀå, ¼±Ã»¼º½ÉÀ庴, °¡¿Í»ç³¢º´, ºÎÁ¤¸Æ, °íÇ÷¾Ð, ÈäÅë, ½Ç½Å
  • Á÷ À§: ºÎ±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
295 (±¹¿Ü)SCIE Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance
294 (±¹¿Ü)SCIE Characteristics and Treatment of Anaphylaxis in Children Visiting a Pediatric Emergency Department in Korea
293 (±¹³»)KCI Clinical Differences between Enterovirus and Human Parechovirus in Children and Infants
292 (±¹¿Ü)SCIE Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report
291 (±¹³»)KCIÈĺ¸ "A Renal Size Discrepancy among the Findings of Renal Sonogram in Children with Their First Episode of Pyelonephritis is One of the Useful Parameters to Predict the Presence of Cortical Defects on the Acute DMSA Renal Scan "
290 (±¹¿Ü)SCI Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
289 (±¹¿Ü)SCIE Comparison of the Immunogenicity and Safety of Three Enhanced Inactivated Poliovirus Vaccines from Different Manufacturers in Healthy Korean Infants: A Prospective Multicenter Study
288 (±¹¿Ü)SCI Association of phthalateswithnasal patency and small airway dysfunctionin first grade elementary schoolchildren
287 (±¹¿Ü)SCI Bidirectional association between GERD and asthma in children: two longitudinal follow-up studies using a national sample cohort
286 (±¹³»)KCIÈĺ¸ Clinical Differences between Enterovirus and Human Parechovirus in Children and Infants
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729